Vitrolife Group technologies help identify more viable embryos
A study shows combining EmbryoScope time-lapse and PGT-A Plus ploidy analysis increases detection of euploid/diploid embryos, especially in abnormally fertilized oocytes.
See the latest news and media coverage for Vitrolife. We track all announcements, press releases, and industry mentions in real time, all in one place.
IVF products and services provider
vitrolife.comLast updated
In short: Vitrolife experienced significant leadership turnover and growth in the North American market while advancing its IVF technology portfolio.
A study shows combining EmbryoScope time-lapse and PGT-A Plus ploidy analysis increases detection of euploid/diploid embryos, especially in abnormally fertilized oocytes.
The study shows higher concordance with experience and suggests AI complements embryologist expertise.
Dr. Robert J. Mendola's study shows bicarbonate buffer outperforms MOPS and HEPES, improving fertilization rates, blastocyst development, and reducing mosaicism.
EmbryoGlue improves pregnancy rates significantly in RIF cases, as shown in a 2012 study (37.5% vs 10.9% for fresh transfers). It mimics natural hyaluronan-rich environment.
Norwegian Ferd has increased its holding to 5.4 percent of capital and votes.
On Friday, Vitrolife announced that CEO Bronwyn Brophy O'Connor is leaving - to take over a company "in another area of the medtech industry". I...
Vitrolife's CEO Bronwyn Brophy O'Connor has decided to leave the company to take up "a CEO role in another area of the medtech industry", according to...
The Annual General Meeting resolved to re-elect the Board members Henrik Blomquist, Karen Lykke Sørensen, Pia Marions and Jón Sigurdsson, and to elect Nicklas Hansen...
Track Vitrolife and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Vitrolife and other trending companies.